Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis

  • Huihui Fan
  • , Huda I. Atiya
  • , Yeh Wang
  • , Thomas R. Pisanic
  • , Tza Huei Wang
  • , Ie Ming Shih
  • , Kelly K. Foy
  • , Leonard Frisbie
  • , Ronald J. Buckanovich
  • , Alison A. Chomiak
  • , Rochelle L. Tiedemann
  • , Scott B. Rothbart
  • , Chelsea Chandler
  • , Hui Shen*
  • , Lan G. Coffman*
  • *Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

47 Scopus citations

Abstract

Fan et al. demonstrate that ovarian cancer reprograms the epigenome of stromal cells, inducing a mesenchymal-to-epithelial transition (MET) to form carcinoma-associated mesenchymal stem cells (CA-MSCs). This MET, mediated by WT1 and EZH2, enables CA-MSC:cancer cell co-metastasis. EZH2 inhibition decreases CA-MSC-mediated metastasis, presenting a potential therapeutic opportunity in ovarian cancer.

Original languageEnglish
Article number108473
JournalCell Reports
Volume33
Issue number10
DOIs
StatePublished - 08 12 2020
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020 The Author(s)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • EZH2
  • WT1
  • carcinoma-associated mesenchymal stem cells
  • epigenomic reprogramming
  • mesenchymal-to-epithelial transition
  • metastasis
  • ovarian cancer
  • tumor microenvironment

Fingerprint

Dive into the research topics of 'Epigenomic Reprogramming toward Mesenchymal-Epithelial Transition in Ovarian-Cancer-Associated Mesenchymal Stem Cells Drives Metastasis'. Together they form a unique fingerprint.

Cite this